EdgarLookup

Neumora Therapeutics, Inc. — 8-K Filings

25 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Neumora Therapeutics, Inc. (NMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Neumora Therapeutics, Inc. has filed 25 8-K documents with the SEC since 2021. To view all SEC filings by Neumora Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 424B4 8-A12B 8-K 8-K/A CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT POS AM POSASR PRE 14A S-1 S-1/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K 8-K 0001193125-26-045526 Feb 11, 2026
8-K 8-K 0001193125-26-009727 Jan 12, 2026
8-K 8-K 0001193125-26-001472 Jan 5, 2026
8-K 8-K 0001193125-25-291352 Nov 21, 2025 Nov 17, 2025
8-K 8-K 0001193125-25-268046 Nov 6, 2025
8-K 8-K 0001193125-25-250677 Oct 27, 2025
8-K 8-K 0001193125-25-250656 Oct 27, 2025
8-K 8-K 0000950170-25-103997 Aug 6, 2025
8-K 8-K 0001193125-25-132307 May 30, 2025 May 28, 2025
8-K 8-K 0001193125-25-121714 May 16, 2025 May 14, 2025
8-K 8-K 0000950170-25-069147 May 12, 2025
8-K 8-K 0000950170-25-030396 Mar 3, 2025
8-K 8-K 0001193125-25-026156 Feb 13, 2025
8-K 8-K 0001193125-25-004999 Jan 13, 2025
8-K 8-K 0001193125-25-000084 Jan 2, 2025
8-K 8-K 0000950170-24-124563 Nov 12, 2024
8-K 8-K 0000950170-24-091205 Aug 6, 2024
8-K 8-K 0001193125-24-161572 Jun 14, 2024 Jun 13, 2024
8-K 8-K 0000950170-24-053933 May 7, 2024
8-K 8-K 0001193125-24-095472 Apr 15, 2024
8-K 8-K 0001193125-24-061473 Mar 7, 2024
8-K 8-K 0001193125-24-003968 Jan 8, 2024
8-K 8-K 0001193125-23-284303 Nov 28, 2023 Nov 27, 2023
8-K 8-K 0001193125-23-268165 Nov 1, 2023
8-K 8-K 0001193125-23-237644 Sep 19, 2023